News-Medical.Net on MSN
Pairing antiviral therapy with immune modulation restores lung repair in lethal Influenza
Recovery from deadly influenza infection may hinge on helping the lungs heal in addition to stopping the virus, according to ...
The field of traditional medicine, with its deep historical roots, offers a multitude of natural compounds with potential therapeutic benefits. Lately, ...
SHELTON, CONNECTICUT / ACCESS Newswire / November 17, 2025 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the “Company”), reports that it has filed its Quarterly Report on Form 10-Q for the fiscal quarter ...
The search for long-COVID treatments echoes the previous struggles against HIV/AIDS. Now researchers are taking lessons from ...
Merck & Co. is spending $9.2 billion for Cidara Therapeutics and its lead influenza antiviral that was dropped by Johnson & ...
We investigate whether cold and flu nose sprays such as Vicks First Defence can help fight off common winter bugs ...
The European Centre for Disease Prevention and Control on Thursday urged people eligible for influenza shots to get ...
On November 14, 2025, Bain Capital Life Sciences Investors, LLC disclosed a purchase of 520,310 shares of Cidara Therapeutics ...
Received FDA IND clearance to evaluate CDI-988 as both norovirus preventive and treatmentExpects to initiate CDI-988 Phase 1b ...
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® ...
Jefferies London Healthcare Conference 2025 November 20, 2025 9:30 AM ESTCompany ParticipantsPeter Dannenbaum - Vice ...
14hon MSN
Merck Is Buying Cidara Therapeutics for $9.2 Billion. Is This the Boost the Lagging Drugmaker Needs?
Over the past two years, Merck ( MRK 0.19%) has faced several challenges, resulting in a decline in the company's share price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results